USE OF A RXR AGONIST IN TREATING CANCER
Publication
EP2026030729A1
Kind: A1
Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
A61K 45/06 20060101AFI20260208BHEP
A61K 31/192 20060101ALI20260208BHEP
A61K 35/17 20250101ALI20260208BHEP
C07K 16/30 20060101ALI20260208BHEP
C12N 5/0783 20100101ALI20260208BHEP
A61P 37/02 20060101ALI20260208BHEP
A61P 35/00 20060101ALI20260208BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR